Work

Tenuigenin ameliorates Alzheimer’s disease by targeting MAP2K1: integrated evidence from network pharmacology and experimental validation

Year: 2025
Type: article
Source: Neuroreport
Language: English
Subfield: Physiology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7117485391
FWCI:
Cites: 50
Cited by:
Related to: